News
19h
GlobalData on MSNRemeGen’s telitacicept achieves Phase III win in Sjögren’s syndrome
The drug met its primary endpoints in a Chinese trial, while a Phase III trial in Sjögren's syndrome is currently underway in ...
China-based RemeGen has announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, ...
World No. 1 Jannik Sinner has yet to drop a set at the Cincinnati Open heading into the quarterfinals. Sinner will face Felix ...
14h
TipRanks on MSNAmgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 study titled ‘A Phase 3 Randomized, ...
Coco Gauff advanced to the fourth round of the Cincinnati Open after her opponent withdrew due to illness. Gauff will have ...
Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...
14h
TipRanks on MSNBristol-Myers Squibb’s Promising Phase 3 Study on Deucravacitinib for Sjögren’s Syndrome
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting a ...
Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...
Bristol-Myers Squibb Company announced a significant update in their Sjögren’s Syndrome study. The Phase 3 study tests ...
14h
The Manila Times on MSNVenus Williams returning to US Open at age 45
VENUS Williams is back on the professional tennis tour at age 45 and will be returning to the US Open next week for her first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results